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Autophagy is required to maintain liver 
homeostasis
• through elimination of aggregate-prone 
proteins and damaged mitochondria
• by counteracting hepatocyte swelling
Genetic models have shown that inhibition 
of autophagy genes favors the development 
of liver tumors
Liver macroautophagy declines in obese 
mice
Acute alcohol consumption induces hepatic 
autophagy. By contrast, chronic alcohol 
consumption suppresses hepatic autophagy
Both hepatitis B and C viruses subvert 
autophagy for their own benefit 
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s the AMP-activated protein kinase, which simulta-
ORC1 and activates the ULK1 complex. Moreover, 
utophagy by phosphorylating Beclin 1 in the Beclin 
[9]. Insulin and growth factors activate mTORC1 in a 
anner. Insulin also inhibits autophagy in an mTOR-
er, through, for example, transcriptional downregula-
 genes. In the liver of a starved animal, autophagy 
8 h, and CMA is stimulated. The decline in the pro-
cids by bulk autophagy is associated with the de-
enesis at this stage [3] and ketone bodies may take 
n mechanism of CMA [10].
 pathology
abolic disease
clines in obese mice. Hyperinsulinemia, hyperacti-
d downregulation of ATG5, ATG7, and Beclin 1 may 
nregulation of autophagy [3,4]. Hepatic triglyceride 
tents are increased in hepatic Atg7-deficient mice, 
ophagy plays a key role in regulating hepatic lipid 
ess plays a crucial role in the link between obesity, 
lin-resistance, and type 2 diabetes. Forced expres-
liver of obese mice reduces ER stress, and improves 
and insulin sensitivity. Stimulating autophagy may 
ssion of steatosis in non-alcoholic steatohepatitis 
the role of autophagy in obesity and insulin resis-
ecause induction of the mitokine Fgf21 induces re-
ced obesity and improves insulin resistance in mice 
agy deficiency [11]. Lipophagy is probably involved 
lipid droplets observed during the activation of stel-
 onset of liver fibrosis [12].
onsumption, via the production of reactive oxygen 
epatic autophagy, presumably as an initial attempt 
 effect of alcohol by the selective removal of lipid 
ged mitochondria [13]. By contrast, chronic alco-
uppresses hepatic autophagy. This is probably the 
duced AMPK activity and of the inhibition by etha-
nsport required for autophagosome formation [14]. 
ockade of autophagy favors the accumulation of 
oteins, hyperactivation of Nrf2 (via the accumulation 
nd accumulation of damaged mitochondria, leading 
ctious diseases
d C viruses subvert autophagy for their own ben-
rotein HBx stimulates autophagosome formation by 
ity of the Beclin 1:Vps34 complex, without increas-
in degradation. Autophagy proteins and autophagy 
uired for HBV viral replication and morphogenesis. 
 autophagosomes is also observed in HCV-infected 
y machinery promotes the initial steps in HCV rep-
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auackground
he term “autophagy” covers three processes responsible for the ly-
osomal degradation of cell components: macroautophagy, micro-
utophagy, and chaperone-mediated autophagy (CMA) of proteins 
ontaining a KFERQ motif [1]. Macroautophagy and microautophagy 
an be non-selective processes, but in many cases they can also be 
ighly selective for organelles, lipid droplets, aggregate-prone proteins, 
r microorganisms invading the cytoplasm. The paradigm for selective 
acroautophagy is the recognition of the cargo by autophagy receptors 
at connect the cargo to the autophagy machinery. For example, the 
utophagy receptor SQSTM1/p62 recognizes ubiquitinated, tagged pro-
in aggregates via its ubiquitin-associated domain, and recognizes the 
utophagy protein microtubule-associated protein 1 light chain 3, LC3, 
ia its LC3-interacting region (LIR) motif [2].
Microautophagy is the direct engulfment of cytoplasmic material by the 
sosomal membrane, whereas macroautophagy starts with the forma-
on of a double-membrane surrounded vacuole, known as the autopha-
osome, which ultimately fuses with the lysosomal compartment where 
e sequestered material is degraded. The autophagosome originates 
om a membrane known as the phagophore, the nucleation and elon-
ation of which depend on the autophagy-related (ATG) genes, which 
ere originally discovered in the yeast Saccharomyces cerevisiae and 
re well conserved in mammals [2]. The UNC-51-like kinase 1 ULK1 
TG1) complex initiates phagophore formation in an endoplasmic re-
culum (ER)-based structure known as the omegasome. The activity of 
is complex is controlled by the mammalian target of rapamycin com-
lex 1 (mTORC1), which integrates signals from amino acids, glucose, 
nd insulin (growth factors) [3]. Dissociation of mTORC1 from the ULK1 
omplex under starvation conditions initiates autophagosome forma-
on. The ULK1 complex acts in a coordinated manner with Beclin 1 
TG6):Vps34 (class III phosphatidylinositol 3-kinase) complex I. The 
roduction of PtdIns3P by vacuolar protein sorting 34 (Vps34) is an im-
ortant trigger for the elongation and closure of the autophagosome by 
o ubiquitin-like conjugation systems, ATG5-ATG12 and LC3 (ATG8)-
E (phosphatidylethanolamine).
utophagy in liver physiology and metabolism
he basal rate of macroautophagy (hereafter referred to as ‘autophagy’) 
 required to maintain liver homeostasis through the elimination of ag-
regate-prone proteins and damaged mitochondria and by counteract-
g hepatocyte swelling [4]. Blockade of basal autophagy interferes with 
e cell quality control and leads to hepatomegaly, which is followed by 
flammation, hepatitis, and tumorigenesis. Suppression of autophagy 
sults in the accumulation of SQSTM1, which acts as a signaling hub 
 activate the NF-kB signaling pathway, the transcription of genes en-
oding for antioxidant proteins, and detoxification enzymes via the acti-
ation of the Nrf2 transcription factor [4]. The importance of the quality 
ontrol of autophagy is illustrated in the classic form of α1-antitrypsin 
eficiency, where the mutant protein accumulates in the ER and forms 
trahepatic inclusions. By stimulating autophagy, carbamazepine re-
uces the severity of α1-antitrypsin deficiency in a mouse model [5]. 
MA also contributes to the elimination of damaged proteins and to the 
of glucose activate
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 During periods of fasting, autophagy contributes to gluconeogenesis, 
-oxidation of fatty acids and to ketone body formation. Amino acids 
sed for gluconeogenesis are produced by proteolysis through bulk 
utophagy [3], whereas fatty acids are mainly produced by selective 
utophagy of triglycerides stored in lipid droplets (lipophagy) [7]. Au-
phagy probably also controls the level of very-low-density lipoprotein 
LDL) particles through lipophagy, which releases fatty acids and de-
rades apolipoprotein B. Liver autophagy plays a key role in restoring 
lasma glucose concentrations in neonates during fasting [8]. Liver au-
phagy is also hormonally controlled: insulin inhibits while glucagon 
timulates the process [3]. The mTORC1 complex, together with Rag 
nd Rheb GTPases, plays a major role in autophagy control by inte-
rating nutritional signals. Amino acids and glucose repress autophagy 
ia the Rag-dependent activation of mTORC1. In addition, the absence 
Autophagy and hepatocellular carcinoma (HCC)
Genetic models have shown that inhibition of autophagy genes favors 
the development of liver tumors [4]. Not only do mice heterozygous for 
Beclin 1 show a high frequency of spontaneous HCC, they also dis-
play accelerated development of HBV-induced, small-cell dysplasia [14]. 
Accordingly, the expression of Beclin 1 is lower in HCC cells than in 
adjacent non-tumor cells. Inhibition of autophagy leads to the accumula-
tion of SQTSM1/p62, which in turn leads to persistent activation of the 
NF-kB pathway and Nrf2. SQSTM1/p62 knockout markedly suppresses 
liver adenoma growth in mice specifically lacking Atg7 in the liver [4]. 
The activation of Nrf2 redirects glucose and glutamine into anabolic 
pathways such as the pentose phosphate pathway and purine nucleo-
tide synthesis, which support tumor cell proliferation [15].
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g. Autophagy in the liver. (A) The autophagic pathway. (B) Autophagy in liver metabolism. (C) Autophagy and liver disease. (D) Autophagy in liver viral infections. CMA, chaperone-mediated 
tophagy; LAH, lysosomal acid hydrolases; HBV, hepatitis B virus; HCV, hepatitis C virus; UPR, unfolded protein response; HCC, hepatocellular carcinoma.
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